Abstract
The human chronic myelogenous leukemia cell line K562 expresses a structurally altered c‐abl protein with tyrosine kinase activity. Erythroid differentiation of K562 cells was induced by tyrosine kinase inhibitors, but not by other kinase inhibitors. Treatment of K562 cells with 5'd(TACTGGCCGCTG‐AAGGGC)3′, complementary to the second exon (codons 2 to 7) of c‐abl mRNA, inhibited cell growth and induced benzidine‐positive cells in a dose‐dependent manner. However, exposure to the sense oligomer did not induce erythroid differentiation of the cells. These results suggest that inhibition of abl tyrosine kinase activity is closely related to induction of erythroid differentiation of K562 cells. A multidrug‐resistant subline (K562R) was induced to undergo erythroid differentiation by tyrosine kinase inhibitors such as genistein or herbimycin A as effectively as the parent K562 cells were. Therefore, tyrosine kinase inhibitors might be useful as cancer chemotherapeutic agents against some multidrug‐resistant leukemias having abnormally high activity of oncogene tyrosine kinase(s).
Keywords: K562, Differentiation, abl, oncogene, Antisense oligomer, Tyrosine kinase inhibitor
Full Text
The Full Text of this article is available as a PDF (256.5 KB).
REFERENCES
- 1. ) Bishop , J.Cellular oncogenes and retroviruses . Annu. Rev. Biochem. , 52 , 301 – 354 ( 1983. ). [DOI] [PubMed] [Google Scholar]
- 2. ) Knopka , J. and Witte , O. N.Activation of the abl oncogene in murine and human leukemias . Biochim. Biophys. Acta , 823 , 1 – 17 ( 1985. ). [DOI] [PubMed] [Google Scholar]
- 3. ) Ramakrishnan , L. and Rosenberg , N.abl genes . Biochim. Biophys. Acta , 989 , 209 – 224 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 4. ) Honma , Y. , Okabe‐Kado , J. , Hozumi , M. , Uehara , Y. and Mizuno , S.Induction of erythroid differentiation of K562 human leukemic cells by herbimycin A, an inhibitor of tyrosine kinase activity . Cancer Res. , 49 , 331 – 334 ( 1989. ). [PubMed] [Google Scholar]
- 5. ) Lozzio , C. B. and Lozzio , B. B.Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome . Blood , 45 , 321 – 334 ( 1975. ). [PubMed] [Google Scholar]
- 6. ) Anderson , L. C. , Nilsson , K. and Gahmberg , C. G.K562‐a human erythroleukemia cell line . Int. J. Cancer , 23 , 143 – 147 ( 1979. ). [DOI] [PubMed] [Google Scholar]
- 7. ) Rowley , P. T. , Ohlsson‐Wilhelm , B. M. , Farley , B. A. and LaBella , S.Inducers of erythroid differentiation of K562 human leukemia cells . Exp. Hematol. , 9 , 32 – 37 ( 1981. ). [PubMed] [Google Scholar]
- 8. ) Hozumi , M.Fundamentals of chemotherapy of myeloid leukemia by induction of leukemia cell differentiation . Adv. Cancer Res. , 38 , 121 – 169 ( 1983. ). [DOI] [PubMed] [Google Scholar]
- 9. ) Umezawa , H. , Imoto , M. , Sawa , T. , Isshiki , K. , Matsuda , N. , Uchida , T. , Iinuma , H. , Hamada , M. and Takeuchi , T.Studies on a new epidermal growth factor‐ receptor kinase inhibitor, erbstatin, produced by MH435‐hF3 . J. Antibiot. , 39 , 170 – 173 ( 1986. ). [DOI] [PubMed] [Google Scholar]
- 10. ) Caraciolo , D. , Valtieri , M. , Venturelli , D. , Pescle , C. , Gewirtz , A. M. and Calabretta , B.Lineage‐specific requirement of c‐abl function in normal hematopoiesis . Science , 245 , 1107 – 1110 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 11. ) Bresser , J. , Doering , J. and Gillespie , D.Quick‐blot: selective mRNA or DNA immobilization from whole cells . DNA , 2 , 243 – 254 ( 1983. ). [DOI] [PubMed] [Google Scholar]
- 12. ) Akiyama , T. , Ishida , J. , Nakagawa , S. , Ogawara , H. , Watanabe , S. , Itoh , N. , Shibuya , M. and Fukami , Y.Genistein, a specific inhibitor of tyrosine‐specific protein kinases . J. Biol. Chem. , 262 , 5592 – 5595 ( 1987. ). [PubMed] [Google Scholar]
- 13. ) Uehara , Y. , Hori , M. , Takeuchi , T. and Umezawa , H.Screening of agents which convert ‘transformed morpholog’ of Rous sarcoma virus‐infected rat kidney cells to normal morpholog': identification of an active agent as herbimycin and its inhibition of intracellular src kinase . Jpn. J. Cancer Res. , 76 , 672 – 675 ( 1985. ). [PubMed] [Google Scholar]
- 14. ) Uehara , Y. , Fukazawa , H. , Murakami , Y. and Mizuno , S.Irreversible inhibition of v‐src tyrosine kinase activity by herbimycin A and its abrogation by sulfhydryl compounds . Biochem. Biophys. Res. Commun. , 163 , 803 – 809 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 15. ) Uehara , Y. , Murakami , Y. , Mizuno , S. and Kawai , S.Inhibition of transforming activity of tyrosine kinase oncogenes by herbimycin A . Virology , 164 , 294 – 298 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 16. ) Okabe‐Kado , J. , Hayashi , M. , Honma , Y. , Hozumi , M. and Tsuruo , T.Effects of inducers of erythroid differentiation of human leukemia K562 cells on vincristine‐resistant K562/VCR cells . Leuk. Res. , 7 , 481 – 485 ( 1983. ). [DOI] [PubMed] [Google Scholar]